Biotech

All Articles

After FDA turndown as well as layoffs, Lykos CEO is leaving

.Lykos CEO and also creator Amy Emerson is leaving, with principal functioning policeman Michael Mul...

Novartis sparks brand-new stage of Voyager contract with $15M capsid offer

.Novartis is opening a new outpost in its own cooperation along with Voyager Rehabs, paying $15 thou...

Lilly posts even more positive data on its own regular the hormone insulin prospect

.On the heels of an FDA being rejected for its primary rivalrous Novo Nordisk, Eli Lilly is making h...

IN 8bio halts phase 2 trial, lays off fifty percent of labor force

.Just a handful of months after dosing the first individual in a phase 2 test for recently diagnosed...

Lilly, Haya ink $1B biobuck being overweight pact to search dark genome

.Eli Lilly's look for obesity intendeds has actually led it to the darker genome. The Big Pharma has...

ArsenalBio raises $325M, pivots off of former lead asset

.Arsenal Biosciences is proceeding up. The cell therapy firm has added on $325 million in ammo along...

Lilly- backed fat burning biotech data IPO

.After increasing $170 million back in February, metabolic disease-focused BioAge Labs has submitted...

Aelis' marijuana usage medication fails phase 2b, driving Indivior to reconsider $100M possibility

.Aelis Farma's hopes of protecting a simple, favorable decision on a $100 million possibility paymen...

ProKidney standstills period 3 trial certainly not needed to have for cell therapy confirmation

.ProKidney has actually ceased one of a pair of period 3 tests for its own cell therapy for renal il...

Vaxcyte rises on 'spectacular' 31-valent PCV gain versus Pfizer

.Vaxcyte revealed what experts called "stunning" period 1/2 data for its 31-valent pneumococcal vacc...